Comparative Effectiveness of Positron Emission Mammography and MRI in the Contralateral Breast of Women With Newly Diagnosed Breast Cancer

2012 ◽  
Vol 198 (1) ◽  
pp. 219-232 ◽  
Author(s):  
Wendie A. Berg ◽  
Kathleen S. Madsen ◽  
Kathy Schilling ◽  
Marie Tartar ◽  
Etta D. Pisano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Comparative Effectiveness ◽  
Contralateral Breast ◽  
Newly Diagnosed ◽  
Positron Emission Mammography ◽  
Positron Emission

scholarly journals Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast

Radiology ◽  
2011 ◽  
Vol 258 (1) ◽  
pp. 59-72 ◽  
Author(s):  
Wendie A. Berg ◽  
Kathleen S. Madsen ◽  
Kathy Schilling ◽  
Marie Tartar ◽  
Etta D. Pisano ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Comparative Effectiveness ◽  
Ipsilateral Breast ◽  
Presurgical Planning ◽  
Positron Emission Mammography ◽  
Positron Emission

Positron emission mammography in the diagnosis of breast cancer

2016 ◽  
Vol 55 (01) ◽  
pp. 15-20 ◽  
Author(s):  
J. Farahati ◽  
A. G. Müller ◽  
E. Gillman ◽  
M. Hentschel ◽  
F. H. H. Müller
Keyword(s):  
Breast Cancer ◽  
High Specificity ◽  
Diagnostic Value ◽  
Glandular Tissue ◽  
Breast Cancer Patients ◽  
Malignant Tumours ◽  
Benign Lesions ◽  
Interventional Study ◽  
Positron Emission Mammography ◽  
Positron Emission

SummaryAim: To evaluate the diagnostic value (sensitivity, specificity) of positron emission mammography (PEM) in a single site non-interventional study using the maximum PEM uptake value (PUVmax). Patients, methods: In a singlesite, non-interventional study, 108 patients (107 women, 1 man) with a total of 151 suspected lesions were scanned with a PEM Flex Solo II (Naviscan) at 90 min p.i. with 3.5 MBq 18F-FDG per kg of body weight. In this ROI(region of interest)-based analysis, maximum PEM uptake value (PUV) was determined in lesions, tumours (PUVmaxtumour), benign lesions (PUVmaxnormal breast) and also in healthy tissues on the contralateral side (PUVmaxcontralateral breast). These values were compared and contrasted. In addition, the ratios of PUVmaxtumour / PUVmaxcontralateral breast and PUVmaxnormal breast / PUVmaxcontralateral breast were compared. The image data were interpreted independently by two experienced nuclear medicine physicians and compared with histology in cases of suspected carcinoma. Results: Based on a criteria of PUV>1.9, 31 out of 151 lesions in the patient cohort were found to be malignant (21%). A mean PUVmaxtumour of 3.78 ± 2.47 was identified in malignant tumours, while a mean PUVmaxnormal breast of 1.17 ± 0.37 was reported in the glandular tissue of the healthy breast, with the difference being statistically significant (p < 0.001). Similarly, the mean ratio between tumour and healthy glandular tissue in breast cancer patients (3.15 ± 1.58) was found to be significantly higher than the ratio for benign lesions (1.17 ± 0.41, p < 0.001). Conclusion: PEM is capable of differentiating breast tumours from benign lesions with 100% sensitivity along with a high specificity of 96%, when a threshold of PUVmax >1.9 is applied.

MR Imaging Screening of the Contralateral Breast in Patients with Newly Diagnosed Breast Cancer: Preliminary Results

Radiology ◽  
2003 ◽  
Vol 226 (3) ◽  
pp. 773-778 ◽  
Author(s):  
Steven G. Lee ◽  
Susan G. Orel ◽  
Irene J. Woo ◽  
Eva Cruz-Jove ◽  
Mary E. Putt ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mr Imaging ◽  
Contralateral Breast ◽  
Newly Diagnosed ◽  
Preliminary Results

The potential role of positron emission mammography for detection of breast cancer. A phantom study

2000 ◽  
Vol 27 (8) ◽  
pp. 1943-1954 ◽  
Author(s):  
Raymond R. Raylman ◽  
Stan Majewski ◽  
Randy Wojcik ◽  
Andrew G. Weisenberger ◽  
Brian Kross ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Potential Role ◽  
Phantom Study ◽  
Positron Emission Mammography ◽  
Positron Emission

Detection of Malignant lesion in Contralateral Breast in Newly Diagnosed Patients of Unilateral Carcinoma Breast on MRI

2020 ◽  
Vol 10 (2) ◽  
Author(s):  
Ghazala Wahid ◽  
Naila Tamkeen ◽  
Anjum Naz ◽  
Maimoona Afsar ◽  
Amina Ashraf ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Clinical Examination ◽  
Bilateral Breast Cancer ◽  
Malignant Lesion ◽  
Contralateral Breast ◽  
Radiology Department ◽  
Newly Diagnosed ◽  
Unilateral Breast Cancer ◽  
Carcinoma Breast ◽  
Increased Risk

Background: Women having unilateral breast cancer have added risk of contralateral breast cancer with an incidence of 1-5% synchronous cancer. There is also increased risk of metachronous cancer in contralateral breast . Female patients with bilateral breast cancer have grave prognosis in comparison to those with unilateral breast cancer. MRI breast is used to assess the multifocality and multicentricity of tumour. Objective: To determine the diagnostic performance of MRI in detecting malignant lesion in contralateral breast in newly diagnosed patients of unilateral carcinoma breast.Material and Methods: In this study total 150 newly diagnosed patients of unilateral breast cancer with normal mammographic and clinical examination of other breast were included. Study was conducted in Radiology department, Hayatabad Medical Complex Peshawar from Jan 2017 to March 2020. MRI scan of normal breast was done on a 1.5 Tesla magnet with multi-channel breast coil. For evaluating the breast lesions, administration of IV contrast and high spatial resolution is necessary .The malignant lesions of breast found on MRI were confirmed histo-pathologically. Results: In 5 out of total 150 women included in study, MRI detected occult breast cancer in the opposite breast in whom clinical examination and mammography was normal (3.3%). 18 women (12.5 %) out of total 150 with positive findings on MRI underwent biopsy, and 5 specimens turned out to be carcinoma (27%). Conclusion: MRI is very useful and helpful to detect occult malignancy in opposite breast which are not detected clinically or by mammography at the time of the initial diagnosis of carcinoma breast.

Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET

2017 ◽  
Vol 42 (3) ◽  
pp. 169-175 ◽  
Author(s):  
Mutsumi Noritake ◽  
Kazutaka Narui ◽  
Tomohiro Kaneta ◽  
Sadatoshi Sugae ◽  
Kentaro Sakamaki ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Neoadjuvant Chemotherapy ◽  
Fdg Pet ◽  
Whole Body ◽  
Positron Emission Mammography ◽  
Positron Emission ◽  
18F Fdg

The current status of positron emission mammography in breast cancer diagnosis

Breast Cancer ◽  
2012 ◽  
Vol 20 (2) ◽  
pp. 123-130 ◽  
Author(s):  
Vasileios Kalles ◽  
George C. Zografos ◽  
Xeni Provatopoulou ◽  
Dimitra Koulocheri ◽  
Antonia Gounaris
Keyword(s):  
Breast Cancer ◽  
Cancer Diagnosis ◽  
Breast Cancer Diagnosis ◽  
Current Status ◽  
Positron Emission Mammography ◽  
Positron Emission

The Value of Positron Emission Mammography (PEM) in Management of Breast Cancer

2013 ◽  
Vol 3 (2) ◽  
pp. S24 ◽  
Author(s):  
T. Khanna ◽  
H. El-Arousy ◽  
N. Thakur ◽  
R. Khanna ◽  
G. Arora
Keyword(s):  
Breast Cancer ◽  
Positron Emission Mammography ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document